Peering Into Bristol-Myers Squibb's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Bristol-Myers Squibb (NYSE:BMY) has seen a 13.58% increase in short interest since its last report, with 37.25 million shares sold short, representing 1.84% of its float. This increase in short interest could indicate a more bearish market sentiment towards BMY, although it has less short interest compared to its peers' average of 4.07%. The article suggests that an increase in short interest does not necessarily predict a decline in stock price.
April 12, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Bristol-Myers Squibb's short interest has increased, indicating potential bearish sentiment, but remains below peer average.
The increase in short interest suggests a bearish outlook from some investors, but the fact that BMY's short interest is below its peer average and the article's suggestion that increased short interest doesn't necessarily lead to a price drop, makes the short-term impact on BMY's stock price uncertain.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90